Application Note

icIEF Analysis Of Adeno-Associated Virus (AAV) Proteins For Gene Therapy

Source: bio-techne
Bio-techne Maurice

In medicine, gene therapy is the process where nucleic acids are delivered to a patient’s cells as a therapeutic drug to treat genetic diseases including hematological, immunological, neurodegenerative, and metabolic disorders, as well as several types of cancers. Once in the nucleus, the therapeutic DNA or RNA replaces a mutant gene with a functional gene, knocks-out a mutated gene that is functioning incorrectly, or introduces a new gene into the body to help fight disease. Moreover, the development of versatile gene-editing technologies like CRISPR, which make it faster and more reliable to modify target DNA, elevates the promise gene therapy holds as a potential treatment option.

All gene therapies utilize either viral or non-viral vectors to deliver the DNA or RNA into the host cell. Viral vectors infect the host cell to introduce the genetic material and are more efficient at transfecting the host cell compared to non-viral vectors like cationic lipids or chemical carriers. However, they can have immunogenic side effects depending on the specific virus used. Therefore, the choice of appropriate viral vector is a critical component when developing the drug. Adeno-associated virus (AAV) is non-pathogenic, and thus incurs only minimal immune response, making it an ideal gene therapy vector.

As with all therapeutic drugs, product characterization is of utmost importance in order to ensure drug safety and stability. For gene therapies, this includes characterizing the delivery vector before the drug is packaged. In this study, we demonstrate how imaged-capillary isoelectric focusing (icIEF) can be used to characterize the charge heterogeneity of AAV vectors to ensure product stability and identity. Maurice delivers this critical analysis as an automated platform that removes the variability typically encountered with platforms that require more hands-on time, and generates high-resolution data in less than 10 minutes. More importantly, Maurice offers 3-5x higher sensitivity than absorbance with the native fluorescence detection mode, offering significant advantages when characterizing low concentration AAV samples.

Request A Quote

VIEW THE APPLICATION NOTE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: